OVERVIEW: Rapid changes in technology, and the incompatibility between the culture of an established corporation and a startup company, make it difficult for many large corporations to maintain their technological edge, even with their access to more resources and widespread distribution systems. However, the capital markets enable an approach to commercializing discontinuous innovations in a time of creative destruction based on leveraging the "patient money" aspect of venture capital. Such an approach may well shape the 21st century information technology corporation and its central R&D laboratory.
Document Type: Research Article
Publication date: November 1, 2001
More about this publication?
Research-Technology Management has been publishing peer-reviewed articles covering the entire spectrum of technological innovation since 1958. RTM is a leading source of knowledge and best practices on innovation management, from research and development through product development to marketing, for leaders of research, development, and engineering worldwide.